Document 0265
 DOCN  M94A0265
 TI    Mucormycosis (zygomycosis): is there news for the clinician?
 DT    9412
 AU    Boelaert JR; Unit of Renal and Infectious Diseases, Brugge, Belgium.
 SO    J Infect. 1994 May;28 Suppl 1:1-6. Unique Identifier : AIDSLINE
       MED/94358451
 AB    New data on mucormycosis (zygomycosis), relevant to the clinician, are
       analysed. Several clinical associations of this fungal infection have
       recently emerged: the association with therapy with the metal chelator
       desferrioxamine (mainly in dialysis patients), the rarity of
       mucormycosis in AIDS patients and its sporadic occurrence after bone
       marrow transplantation. New imaging techniques should be used serially
       in the case of rhinocerebral mucormycosis in order to evaluate the
       extent of the lesions and to guide potential surgery. Surgical
       debridement significantly improves the prognosis of rhinocerebral
       mucormycosis. Finally, results of the use of liposomal amphotericin B in
       a few patients with rhinocerebral mucormycosis are reviewed.
 DE    AIDS-Related Opportunistic Infections  Deferoxamine/*ADVERSE EFFECTS
       Disease Susceptibility  Drug Therapy/TRENDS  Human  *Mucormycosis/DRUG
       THERAPY  Organ Transplantation  JOURNAL ARTICLE  REVIEW  REVIEW,
       TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).